Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
customers are asked if they wish to share their data for research
potayto potahto - 23andMe making a profit or not changes nothing to the customers. Would it make you feel better if they just gave out the data for free?